Stock News

WSJ: Pfizer considering buying Global Blood Therapeutics for roughly $5 billion


Shares of Global Blood Therapeutics Inc.

jumped 9.5% in trading on Friday after The Wall Street Journal reported that Pfizer Inc.

is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Therapeutics, which markets a sickle-cell treatment, is attracting takeover interest. The company’s stock is up 79.6% this year, while the broader S&P 500

is down 12.8%.

Bed Bath & Beyond is discontinuing a private brand as it tries to reverse declining sales

Previous article

Here’s Why Rich Americans Are Moving Here

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Stock News